Human Molecular Genetics Advance Access originally published online on April 28, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 12 1275-1286
DOI: 10.1093/hmg/ddh142
Human Molecular Genetics, Vol. 13, No. 12 © Oxford University Press 2004; all rights reserved
X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2–/+ mouse brain
Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, 1 Shields Avenue, University of California, Davis, CA 95616, USA
Received March 14, 2004; Revised April 5, 2004; Accepted April 15, 2004
Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in MECP2, encoding methyl-CpG-binding protein 2 (MeCP2). The onset of symptoms in RTT is delayed until 6–18 months and 4–6 months in the Mecp2–/+ mouse model, corresponding to a dynamic and gradual accumulation of MeCP2 expression in individual neurons of the postnatal brain. Because of X chromosome inactivation (XCI), cells within RTT females are mosaic for expression of the heterozygous MECP2 mutation. Using the targeted Mecp2 mouse model, we investigated the effect of Mecp2 mutation on XCI and developmental MeCP2 expression in wild-type (wt)-expressing neurons by quantitative laser scanning cytometry. Mecp2–/+ female mice exhibited uniform regional distribution of Mecp2 mutant-expressing cells in brain, but unbalanced XCI in the population, favoring expression of the Mecp2 wt allele. Interestingly, MeCP2 expression in Mecp2 wt-expressing cells from Mecp2–/+ mice was significantly lower than those from Mecp2+/+ age-matched controls. The negative effect of Mecp2 mutation on wt Mecp2 expression correlated with the percentage of Mecp2 mutant-expressing cells in the cortex. Similar results were observed in two RTT females with identical MECP2 mutations but different XCI ratios. These results demonstrate that Mecp2-mutant neurons affect the development of surrounding neurons in a non-cell-autonomous manner and suggest that environmental influences affect the level of MeCP2 expression in wt neurons. These results help in explaining the role of XCI in the pathogenesis of RTT and have important implications in designing therapies for female RTT patients.
* To whom correspondence should be addressed at: Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, 1 Shields Avenue, University of California, Davis, CA 95616, USA. Tel: +1 5307547598; Fax: +1 5307528692; Email: jmlasalle{at}ucdavis.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Maezawa, S. Swanberg, D. Harvey, J. M. LaSalle, and L.-W. Jin Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions J. Neurosci., April 22, 2009; 29(16): 5051 - 5061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Swanberg, R. P. Nagarajan, S. Peddada, D. H. Yasui, and J. M. LaSalle Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism Hum. Mol. Genet., February 1, 2009; 18(3): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kerr, M. Alvarez-Saavedra, M. A. Saez, A. Saona, and J. I. Young Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice Hum. Mol. Genet., June 15, 2008; 17(12): 1707 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G.M. Jugloff, K. Vandamme, R. Logan, N. P. Visanji, J. M. Brotchie, and J. H. Eubanks Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice Hum. Mol. Genet., May 15, 2008; 17(10): 1386 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nomura, M. Kimura, T. Horii, S. Morita, H. Soejima, S. Kudo, and I. Hatada MeCP2-dependent repression of an imprinted miR-184 released by depolarization Hum. Mol. Genet., April 15, 2008; 17(8): 1192 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Archer, J. Evans, H. Leonard, L. Colvin, D. Ravine, J. Christodoulou, S. Williamson, T. Charman, M. E S Bailey, J. Sampson, et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation J. Med. Genet., February 1, 2007; 44(2): 148 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Huppke, E M Maier, A Warnke, C Brendel, F Laccone, and J Gartner Very mild cases of Rett syndrome with skewed X inactivation J. Med. Genet., October 1, 2006; 43(10): 814 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peddada, D. H. Yasui, and J. M. LaSalle Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome Hum. Mol. Genet., June 15, 2006; 15(12): 2003 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Crawford, K M Lower, R C M Hennekam, H Van Esch, A Megarbane, S A Lynch, G Turner, and J Gecz Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient J. Med. Genet., March 1, 2006; 43(3): 238 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Duncan Armstrong Neuropathology of Rett Syndrome J Child Neurol, September 1, 2005; 20(9): 747 - 753. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, September 1, 2005; 20(9): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
D. D. Armstrong Neuropathology of Rett Syndrome J Child Neurol, August 1, 2005; 20(8): 747 - 753. [Abstract] [PDF]
|
|
|
|
|
|
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, August 1, 2005; 20(8): 768 - 778. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Watson, G. J. Pelka, T. Radziewic, M. D. Shahbazian, J. Christodoulou, S. L. Williamson, and P. P.L. Tam Reduced proportion of Purkinje cells expressing paternally derived mutant Mecp2308 allele in female mouse cerebellum is not due to a skewed primary pattern of X-chromosome inactivation Hum. Mol. Genet., July 1, 2005; 14(13): 1851 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Caballero and B. Hendrich MeCP2 in neurons: closing in on the causes of Rett syndrome Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R19 - R26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Samaco, A. Hogart, and J. M. LaSalle Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3 Hum. Mol. Genet., February 15, 2005; 14(4): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L S Weaving, C J Ellaway, J Gecz, and J Christodoulou Rett syndrome: clinical review and genetic update J. Med. Genet., January 1, 2005; 42(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|